05:57 PM EDT, 09/03/2025 (MT Newswires) -- Edward M. Kaye, Director, on August 29, 2025, sold 61,885 shares in Stoke Therapeutics ( STOK ) for $1,245,698. Following the Form 4 filing with the SEC, Kaye has control over a total of 91,585 common shares of the company, with 91,585 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1623526/000141588925023590/xslF345X05/form4-09032025_090950.xml